Sanbox Reserved 684 - Revision history

Michal Harel at 10:14, 21 February 2016

Michal Harel — Sun, 21 Feb 2016 10:14:47 GMT

←Older revision		Revision as of 10:14, 21 February 2016
Line 1:		Line 1:
-	<applet load='3grf' size='~~500~~' frame='true' align='right' caption='Orthinine Transcarbamoylase' scene='Insert optional scene name here' />=='''Ornithine Transcarbamoylase'''==	+	<applet load='3grf' size='350' frame='true' align='right' caption='Orthinine Transcarbamoylase complex with Ni+2 ion (PDB code [[3grf]])' scene='Insert optional scene name here' />=='''Ornithine Transcarbamoylase'''==
	===='''Introduction'''====		===='''Introduction'''====
	<scene name='Sanbox_Reserved_684/Otc_structure/1'>Orthinine Transcarbamoylase</scene> (OTC) is an enzyme that catalyzes the reaction between carbamoyl phosphate and ornithine to form citrulline and phosphate. In plants and microbes, OTC is involved in arginine biosynthesis, but in mammals it is located in the mitochondria and is part of the urea cycle.		<scene name='Sanbox_Reserved_684/Otc_structure/1'>Orthinine Transcarbamoylase</scene> (OTC) is an enzyme that catalyzes the reaction between carbamoyl phosphate and ornithine to form citrulline and phosphate. In plants and microbes, OTC is involved in arginine biosynthesis, but in mammals it is located in the mitochondria and is part of the urea cycle.

Matthew Heard at 03:21, 15 November 2012

Matthew Heard — Thu, 15 Nov 2012 03:21:43 GMT

←Older revision		Revision as of 03:21, 15 November 2012
Line 5:		Line 5:
	===='''Structure'''====		===='''Structure'''====
	OTC is a trimer. The monomer unit has a CP-binding domain and an amino acid-binding domain. Each of the two discrete substrate-binding domains (SBDs) have an α/β topology with a central β-pleated sheet embedded in flanking α-helices.		OTC is a trimer. The monomer unit has a CP-binding domain and an amino acid-binding domain. Each of the two discrete substrate-binding domains (SBDs) have an α/β topology with a central β-pleated sheet embedded in flanking α-helices.
-	The <scene name='Sanbox_Reserved_684/Active_site_otc/2'>active site</scene> are located at the interface between the protein monomers.<ref>http://en.wikipedia.org/wiki/Ornithine_transcarbamylase</ref>The crystal structure of human ornithine transcarbamylase (OTCase) complexed with carbamoyl phosphate (CP) and L-norvaline (NOR) has been determined to 1.9-A resolution. There are significant differences in the interactions of CP with the protein, compared with the interactions of the CP moiety of the bisubstrate analogue N-(phosphonoacetyl)-L-ornithine (PALO). The carbonyl plane of CP rotates about 60 degrees compared with the equivalent plane in PALO complexed with OTCase. This positions the side chain of NOR optimally to interact with the carbonyl carbon of CP. The mixed-anhydride oxygen of CP, which is analogous to the methylene group in PALO, interacts with the guanidinium group of Arg-92; the primary carbamoyl nitrogen interacts with the main-chain carbonyl oxygens of Cys-303 and Leu-304, the side chain carbonyl oxygen of Gln-171, and the side chain of Arg-330. The residues that interact with NOR are similar to the residues that interact with the ornithine (ORN) moiety of PALO. The side chain of NOR is well defined and close to the side chain of Cys-303 with the side chains of Leu-163, Leu-200, Met-268, and Pro-305 forming a hydrophobic wall. C-delta of NOR is close to the carbonyl oxygen of Leu-304 (3.56 A), S-gamma atom of Cys-303 (4.19 A), and carbonyl carbon of CP (3.28 A). Even though the N-epsilon atom of ornithine is absent in this structure, the side chain of NOR is positioned to enable the N-epsilon of ornithine to donate a hydrogen to the S-gamma atom of Cys-303 along the reaction pathway. Binding of CP and NOR promotes domain closure to the same degree as PALO, and the active site structure of CP-NOR-enzyme complex is similar to that of the PALO-enzyme complex. The structures of the active sites in the complexes of aspartate transcarbamylase (ATCase) with various substrates or inhibitors are similar to this OTCase structure, consistent with their common evolutionary origin.<ref>http://www.proteopedia.org/wiki/index.php/1c9y</ref>	+	The <scene name='Sanbox_Reserved_684/Active_site_otc/2'>active site</scene> are located at the interface between the protein monomers.<ref>http://en.wikipedia.org/wiki/Ornithine_transcarbamylase</ref>The crystal structure of human ornithine transcarbamylase (OTCase) complexed with carbamoyl phosphate (CP) and L-norvaline (NOR) has been determined to 1.9-A resolution. There are significant differences in the interactions of CP with the protein, compared with the interactions of the CP moiety of the bisubstrate analogue N-(phosphonoacetyl)-L-ornithine (PALO). The carbonyl plane of CP rotates about 60 degrees compared with the equivalent plane in PALO complexed with OTCase. This positions the side chain of NOR optimally to interact with the carbonyl carbon of CP. The mixed-anhydride oxygen of CP, which is analogous to the methylene group in PALO, interacts with the guanidinium group of Arg-92; the primary carbamoyl nitrogen interacts with the main-chain carbonyl oxygens of Cys-303 and Leu-304, the side chain carbonyl oxygen of Gln-171, and the side chain of Arg-330. The residues that interact with NOR are similar to the residues that interact with the ornithine (ORN) moiety of PALO. The side chain of NOR is well defined and close to the side chain of Cys-303 with the side chains of Leu-163, Leu-200, Met-268, and Pro-305 forming a hydrophobic wall. C-delta of NOR is close to the carbonyl oxygen of Leu-304 (3.56 A), S-gamma atom of Cys-303 (4.19 A), and carbonyl carbon of CP (3.28 A). Even though the N-epsilon atom of ornithine is absent in this structure, the side chain of NOR is positioned to enable the N-epsilon of ornithine to donate a hydrogen to the S-gamma atom of Cys-303 along the reaction pathway. Binding of CP and NOR promotes domain closure to the same degree as PALO, and the active site structure of CP-NOR-enzyme complex is similar to that of the PALO-enzyme complex. The structures of the active sites in the complexes of aspartate transcarbamylase (ATCase) with various substrates or inhibitors are similar to this OTCase structure, consistent with their common evolutionary origin.<ref>http://www.proteopedia.org/wiki/index.php/1c9y</ref>The binding of carbamyl-P, L-ornithine, and its competitive inhibitor L-norvaline by ornithine transcarbamylase has been measured by gel filtration at 25° under the conditions used for the kinetic experiments. Carbamyl-P forms a reversible binary complex with the enzyme from both liver and Streptococcus faecalis, whereas L-norvaline is bound tightly only in the presence of carbamyl-P. There is the equivalent for each ligand of one site per monomer. Two dissociation constants, differing 10-fold, are required to describe the data for the binding of both carbamyl-P and norvaline by the S. faecalis enzyme, and three, even more widely separated, for the binding of carbamyl-P to the bovine enzyme. L-Ornithine, which is also poorly bound to the free enzyme, is, in contrast to norvaline, tightly bound in the presence of phosphate.<ref>http://www.jbc.org/content/247/6/1654.short</ref>

Nick Shimko at 03:03, 15 November 2012

Nick Shimko — Thu, 15 Nov 2012 03:03:41 GMT

←Older revision		Revision as of 03:03, 15 November 2012
Line 1:		Line 1:
-	=='''Ornithine Transcarbamoylase'''==	+	<applet load='3grf' size='500' frame='true' align='right' caption='Orthinine Transcarbamoylase' scene='Insert optional scene name here' />=='''Ornithine Transcarbamoylase'''==
	===='''Introduction'''====		===='''Introduction'''====
-	~~Ornithine transcarbamoylase~~ (OTC) is an enzyme that catalyzes the reaction between carbamoyl phosphate and ornithine to form citrulline and phosphate. In plants and microbes, OTC is involved in arginine biosynthesis, but in mammals it is located in the mitochondria and is part of the urea cycle.	+	<scene name='Sanbox_Reserved_684/Otc_structure/1'>Orthinine Transcarbamoylase</scene> (OTC) is an enzyme that catalyzes the reaction between carbamoyl phosphate and ornithine to form citrulline and phosphate. In plants and microbes, OTC is involved in arginine biosynthesis, but in mammals it is located in the mitochondria and is part of the urea cycle.
	OTC is often associated with Ornithine transcarbamoylase deficiency (OTCD). OTCD is a common urea cycle disorder, and it is a genetic disorder which results in a mutated and ineffective form of the enzyme OTC.		OTC is often associated with Ornithine transcarbamoylase deficiency (OTCD). OTCD is a common urea cycle disorder, and it is a genetic disorder which results in a mutated and ineffective form of the enzyme OTC.
	===='''Structure'''====		===='''Structure'''====
	OTC is a trimer. The monomer unit has a CP-binding domain and an amino acid-binding domain. Each of the two discrete substrate-binding domains (SBDs) have an α/β topology with a central β-pleated sheet embedded in flanking α-helices.		OTC is a trimer. The monomer unit has a CP-binding domain and an amino acid-binding domain. Each of the two discrete substrate-binding domains (SBDs) have an α/β topology with a central β-pleated sheet embedded in flanking α-helices.
-	The <scene name='~~Sandbox_Reserved_644~~/~~Active_site~~/3'>active ~~sites~~</scene> are located at the interface between the protein monomers.<ref>http://en.wikipedia.org/wiki/Ornithine_transcarbamylase</ref>The crystal structure of human ornithine transcarbamylase (OTCase) complexed with carbamoyl phosphate (CP) and L-norvaline (NOR) has been determined to 1.9-A resolution. There are significant differences in the interactions of CP with the protein, compared with the interactions of the CP moiety of the bisubstrate analogue N-(phosphonoacetyl)-L-ornithine (PALO). The carbonyl plane of CP rotates about 60 degrees compared with the equivalent plane in PALO complexed with OTCase. This positions the side chain of NOR optimally to interact with the carbonyl carbon of CP. The mixed-anhydride oxygen of CP, which is analogous to the methylene group in PALO, interacts with the guanidinium group of Arg-92; the primary carbamoyl nitrogen interacts with the main-chain carbonyl oxygens of Cys-303 and Leu-304, the side chain carbonyl oxygen of Gln-171, and the side chain of Arg-330. The residues that interact with NOR are similar to the residues that interact with the ornithine (ORN) moiety of PALO. The side chain of NOR is well defined and close to the side chain of Cys-303 with the side chains of Leu-163, Leu-200, Met-268, and Pro-305 forming a hydrophobic wall. C-delta of NOR is close to the carbonyl oxygen of Leu-304 (3.56 A), S-gamma atom of Cys-303 (4.19 A), and carbonyl carbon of CP (3.28 A). Even though the N-epsilon atom of ornithine is absent in this structure, the side chain of NOR is positioned to enable the N-epsilon of ornithine to donate a hydrogen to the S-gamma atom of Cys-303 along the reaction pathway. Binding of CP and NOR promotes domain closure to the same degree as PALO, and the active site structure of CP-NOR-enzyme complex is similar to that of the PALO-enzyme complex. The structures of the active sites in the complexes of aspartate transcarbamylase (ATCase) with various substrates or inhibitors are similar to this OTCase structure, consistent with their common evolutionary origin.<ref>http://www.proteopedia.org/wiki/index.php/1c9y</ref>	+	The <scene name='Sanbox_Reserved_684/Active_site_otc/2'>active site</scene> are located at the interface between the protein monomers.<ref>http://en.wikipedia.org/wiki/Ornithine_transcarbamylase</ref>The crystal structure of human ornithine transcarbamylase (OTCase) complexed with carbamoyl phosphate (CP) and L-norvaline (NOR) has been determined to 1.9-A resolution. There are significant differences in the interactions of CP with the protein, compared with the interactions of the CP moiety of the bisubstrate analogue N-(phosphonoacetyl)-L-ornithine (PALO). The carbonyl plane of CP rotates about 60 degrees compared with the equivalent plane in PALO complexed with OTCase. This positions the side chain of NOR optimally to interact with the carbonyl carbon of CP. The mixed-anhydride oxygen of CP, which is analogous to the methylene group in PALO, interacts with the guanidinium group of Arg-92; the primary carbamoyl nitrogen interacts with the main-chain carbonyl oxygens of Cys-303 and Leu-304, the side chain carbonyl oxygen of Gln-171, and the side chain of Arg-330. The residues that interact with NOR are similar to the residues that interact with the ornithine (ORN) moiety of PALO. The side chain of NOR is well defined and close to the side chain of Cys-303 with the side chains of Leu-163, Leu-200, Met-268, and Pro-305 forming a hydrophobic wall. C-delta of NOR is close to the carbonyl oxygen of Leu-304 (3.56 A), S-gamma atom of Cys-303 (4.19 A), and carbonyl carbon of CP (3.28 A). Even though the N-epsilon atom of ornithine is absent in this structure, the side chain of NOR is positioned to enable the N-epsilon of ornithine to donate a hydrogen to the S-gamma atom of Cys-303 along the reaction pathway. Binding of CP and NOR promotes domain closure to the same degree as PALO, and the active site structure of CP-NOR-enzyme complex is similar to that of the PALO-enzyme complex. The structures of the active sites in the complexes of aspartate transcarbamylase (ATCase) with various substrates or inhibitors are similar to this OTCase structure, consistent with their common evolutionary origin.<ref>http://www.proteopedia.org/wiki/index.php/1c9y</ref>

Matthew Heard at 02:35, 15 November 2012

Matthew Heard — Thu, 15 Nov 2012 02:35:15 GMT

←Older revision		Revision as of 02:35, 15 November 2012
Line 14:		Line 14:
	If a person is deficient in OTC, ammonia levels will build up, and this will cause neurological problems. Levels of the amino acids glutamate and alanine will be increased (as these are the amino acids that receive nitrogen from others).		If a person is deficient in OTC, ammonia levels will build up, and this will cause neurological problems. Levels of the amino acids glutamate and alanine will be increased (as these are the amino acids that receive nitrogen from others).
	Levels of urea cycle intermediates may be decreased, as carbamoyl phosphate cannot replenish the cycle. The carbamoyl phosphate instead goes into the uridine monophosphate synthetic pathway. Here orotic acid (one step of this alternative pathway) levels in the blood are increased.		Levels of urea cycle intermediates may be decreased, as carbamoyl phosphate cannot replenish the cycle. The carbamoyl phosphate instead goes into the uridine monophosphate synthetic pathway. Here orotic acid (one step of this alternative pathway) levels in the blood are increased.
-	A potential treatment for the high ammonia levels is to give sodium benzoate, which combines with glycine to produce hippurate, at the same time removing an ammonium group. Biotin also plays an important role in the functioning of the OTC enzyme and has been shown to reduce ammonia intoxication in animal experiment.	+	A potential treatment for the high ammonia levels is to give sodium benzoate, which combines with glycine to produce hippurate, at the same time removing an ammonium group. Biotin also plays an important role in the functioning of the OTC enzyme and has been shown to reduce ammonia intoxication in animal experiment.<ref>http://en.wikipedia.org/wiki/Ornithine_transcarbamylase</ref>

	===='''Mechanism'''====		===='''Mechanism'''====

Matthew Heard at 02:30, 15 November 2012

Matthew Heard — Thu, 15 Nov 2012 02:30:27 GMT

←Older revision		Revision as of 02:30, 15 November 2012
Line 21:		Line 21:
	The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.		The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.

-	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro.<ref>http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDMQFjAA&url=http%3A%2F%2Fdigitalcommons.unl.edu%2Fcgi%2Fviewcontent.cgi%3Farticle%3D1009%26context%3Dchemistrydussault&ei=00qkUPOCIYqs9ATd9YHwBQ&usg=AFQjCNH-HXNQ5-7yov_T0Z-TGxDhjGAXyQ</ref>Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC)<ref>http://www.jbc.org/content/275/26/20012</ref>. Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.	+	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro.<ref>http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDMQFjAA&url=http%3A%2F%2Fdigitalcommons.unl.edu%2Fcgi%2Fviewcontent.cgi%3Farticle%3D1009%26context%3Dchemistrydussault&ei=00qkUPOCIYqs9ATd9YHwBQ&usg=AFQjCNH-HXNQ5-7yov_T0Z-TGxDhjGAXyQ</ref>Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC)<ref>http://www.jbc.org/content/275/26/20012</ref>. Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.<ref>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1144443/)</ref>
		+

	References: {{reflist}}		References: {{reflist}}

Matthew Heard at 02:28, 15 November 2012

Matthew Heard — Thu, 15 Nov 2012 02:28:34 GMT

←Older revision		Revision as of 02:28, 15 November 2012
Line 21:		Line 21:
	The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.		The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.

-	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro.<ref>http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDMQFjAA&url=http%3A%2F%2Fdigitalcommons.unl.edu%2Fcgi%2Fviewcontent.cgi%3Farticle%3D1009%26context%3Dchemistrydussault&ei=00qkUPOCIYqs9ATd9YHwBQ&usg=AFQjCNH-HXNQ5-7yov_T0Z-TGxDhjGAXyQ</ref>Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.	+	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro.<ref>http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDMQFjAA&url=http%3A%2F%2Fdigitalcommons.unl.edu%2Fcgi%2Fviewcontent.cgi%3Farticle%3D1009%26context%3Dchemistrydussault&ei=00qkUPOCIYqs9ATd9YHwBQ&usg=AFQjCNH-HXNQ5-7yov_T0Z-TGxDhjGAXyQ</ref>Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC)<ref>http://www.jbc.org/content/275/26/20012</ref>. Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.

	References: {{reflist}}		References: {{reflist}}

Matthew Heard at 02:23, 15 November 2012

Matthew Heard — Thu, 15 Nov 2012 02:23:08 GMT

←Older revision		Revision as of 02:23, 15 November 2012
Line 5:		Line 5:
	===='''Structure'''====		===='''Structure'''====
	OTC is a trimer. The monomer unit has a CP-binding domain and an amino acid-binding domain. Each of the two discrete substrate-binding domains (SBDs) have an α/β topology with a central β-pleated sheet embedded in flanking α-helices.		OTC is a trimer. The monomer unit has a CP-binding domain and an amino acid-binding domain. Each of the two discrete substrate-binding domains (SBDs) have an α/β topology with a central β-pleated sheet embedded in flanking α-helices.
-	The <scene name='Sandbox_Reserved_644/Active_site/3'>active sites</scene> are located at the interface between the protein monomers.<ref>http://en.wikipedia.org/wiki/Ornithine_transcarbamylase</ref>The crystal structure of human ornithine transcarbamylase (OTCase) complexed with carbamoyl phosphate (CP) and L-norvaline (NOR) has been determined to 1.9-A resolution. There are significant differences in the interactions of CP with the protein, compared with the interactions of the CP moiety of the bisubstrate analogue N-(phosphonoacetyl)-L-ornithine (PALO). The carbonyl plane of CP rotates about 60 degrees compared with the equivalent plane in PALO complexed with OTCase. This positions the side chain of NOR optimally to interact with the carbonyl carbon of CP. The mixed-anhydride oxygen of CP, which is analogous to the methylene group in PALO, interacts with the guanidinium group of Arg-92; the primary carbamoyl nitrogen interacts with the main-chain carbonyl oxygens of Cys-303 and Leu-304, the side chain carbonyl oxygen of Gln-171, and the side chain of Arg-330. The residues that interact with NOR are similar to the residues that interact with the ornithine (ORN) moiety of PALO. The side chain of NOR is well defined and close to the side chain of Cys-303 with the side chains of Leu-163, Leu-200, Met-268, and Pro-305 forming a hydrophobic wall. C-delta of NOR is close to the carbonyl oxygen of Leu-304 (3.56 A), S-gamma atom of Cys-303 (4.19 A), and carbonyl carbon of CP (3.28 A). Even though the N-epsilon atom of ornithine is absent in this structure, the side chain of NOR is positioned to enable the N-epsilon of ornithine to donate a hydrogen to the S-gamma atom of Cys-303 along the reaction pathway. Binding of CP and NOR promotes domain closure to the same degree as PALO, and the active site structure of CP-NOR-enzyme complex is similar to that of the PALO-enzyme complex. The structures of the active sites in the complexes of aspartate transcarbamylase (ATCase) with various substrates or inhibitors are similar to this OTCase structure, consistent with their common evolutionary origin.<ref>http://www.proteopedia.org/wiki/index.php/1c9y<r/ref>	+	The <scene name='Sandbox_Reserved_644/Active_site/3'>active sites</scene> are located at the interface between the protein monomers.<ref>http://en.wikipedia.org/wiki/Ornithine_transcarbamylase</ref>The crystal structure of human ornithine transcarbamylase (OTCase) complexed with carbamoyl phosphate (CP) and L-norvaline (NOR) has been determined to 1.9-A resolution. There are significant differences in the interactions of CP with the protein, compared with the interactions of the CP moiety of the bisubstrate analogue N-(phosphonoacetyl)-L-ornithine (PALO). The carbonyl plane of CP rotates about 60 degrees compared with the equivalent plane in PALO complexed with OTCase. This positions the side chain of NOR optimally to interact with the carbonyl carbon of CP. The mixed-anhydride oxygen of CP, which is analogous to the methylene group in PALO, interacts with the guanidinium group of Arg-92; the primary carbamoyl nitrogen interacts with the main-chain carbonyl oxygens of Cys-303 and Leu-304, the side chain carbonyl oxygen of Gln-171, and the side chain of Arg-330. The residues that interact with NOR are similar to the residues that interact with the ornithine (ORN) moiety of PALO. The side chain of NOR is well defined and close to the side chain of Cys-303 with the side chains of Leu-163, Leu-200, Met-268, and Pro-305 forming a hydrophobic wall. C-delta of NOR is close to the carbonyl oxygen of Leu-304 (3.56 A), S-gamma atom of Cys-303 (4.19 A), and carbonyl carbon of CP (3.28 A). Even though the N-epsilon atom of ornithine is absent in this structure, the side chain of NOR is positioned to enable the N-epsilon of ornithine to donate a hydrogen to the S-gamma atom of Cys-303 along the reaction pathway. Binding of CP and NOR promotes domain closure to the same degree as PALO, and the active site structure of CP-NOR-enzyme complex is similar to that of the PALO-enzyme complex. The structures of the active sites in the complexes of aspartate transcarbamylase (ATCase) with various substrates or inhibitors are similar to this OTCase structure, consistent with their common evolutionary origin.<ref>http://www.proteopedia.org/wiki/index.php/1c9y</ref>
		+

-	===='''Mechanism'''====
-	The side-chain amino group of Orn attacks the carbonyl carbon of CP nucleophilically, to form a tetrahedral transition state, found in the middle. A Charge rearrangement then releases Cit and Pi.
-	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro.<ref>https://www.google.com/#hl=en&sugexp=les%3B&gs_nf=3&gs_mss=Ornithine%20transcarbamylase%20in&tok=0eueaC5bjGY4yeUuw3p3dg&pq=ornithine%20transcarbamylase&cp=37&gs_id=30d&xhr=t&q=Ornithine%20transcarbamylase%20inhibitors&pf=p&safe=off&tbo=d&sclient=psy-ab&oq=Ornithine+transcarbamylase+inhibitors&gs_l=&pbx=1&bav=on.2,or.r_gc.r_pw.r_qf.&fp=689574a48716d7d0&bpcl=38093640&biw=1152&bih=499</ref>


Line 23:		Line 21:
	The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.		The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.

-	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro. Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.	+	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro.<ref>http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDMQFjAA&url=http%3A%2F%2Fdigitalcommons.unl.edu%2Fcgi%2Fviewcontent.cgi%3Farticle%3D1009%26context%3Dchemistrydussault&ei=00qkUPOCIYqs9ATd9YHwBQ&usg=AFQjCNH-HXNQ5-7yov_T0Z-TGxDhjGAXyQ</ref>Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.
		+
		+	References: {{reflist}}

Matthew Heard at 02:09, 15 November 2012

Matthew Heard — Thu, 15 Nov 2012 02:09:51 GMT

←Older revision		Revision as of 02:09, 15 November 2012
Line 16:		Line 16:
	If a person is deficient in OTC, ammonia levels will build up, and this will cause neurological problems. Levels of the amino acids glutamate and alanine will be increased (as these are the amino acids that receive nitrogen from others).		If a person is deficient in OTC, ammonia levels will build up, and this will cause neurological problems. Levels of the amino acids glutamate and alanine will be increased (as these are the amino acids that receive nitrogen from others).
	Levels of urea cycle intermediates may be decreased, as carbamoyl phosphate cannot replenish the cycle. The carbamoyl phosphate instead goes into the uridine monophosphate synthetic pathway. Here orotic acid (one step of this alternative pathway) levels in the blood are increased.		Levels of urea cycle intermediates may be decreased, as carbamoyl phosphate cannot replenish the cycle. The carbamoyl phosphate instead goes into the uridine monophosphate synthetic pathway. Here orotic acid (one step of this alternative pathway) levels in the blood are increased.
-	A potential treatment for the high ammonia levels is to give sodium benzoate, which combines with glycine to produce hippurate, at the same time removing an ammonium group. Biotin also plays an important role in the functioning of the OTC enzyme ~~[1]~~ and has been shown to reduce ammonia intoxication in animal experiment.	+	A potential treatment for the high ammonia levels is to give sodium benzoate, which combines with glycine to produce hippurate, at the same time removing an ammonium group. Biotin also plays an important role in the functioning of the OTC enzyme and has been shown to reduce ammonia intoxication in animal experiment.

	===='''Mechanism'''====		===='''Mechanism'''====
Line 22:		Line 22:

	The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.		The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.
		+
	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro. Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.		N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro. Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.

Matthew Heard at 02:07, 15 November 2012

Matthew Heard — Thu, 15 Nov 2012 02:07:33 GMT

←Older revision		Revision as of 02:07, 15 November 2012
Line 20:		Line 20:
	===='''Mechanism'''====		===='''Mechanism'''====
	[[Image:OTC_reaction.png]]		[[Image:OTC_reaction.png]]
		+
	The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.		The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.
	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro. Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.		N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro. Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.

Matthew Heard at 02:06, 15 November 2012

Matthew Heard — Thu, 15 Nov 2012 02:06:54 GMT

←Older revision		Revision as of 02:06, 15 November 2012
Line 10:		Line 10:
	The side-chain amino group of Orn attacks the carbonyl carbon of CP nucleophilically, to form a tetrahedral transition state, found in the middle. A Charge rearrangement then releases Cit and Pi.		The side-chain amino group of Orn attacks the carbonyl carbon of CP nucleophilically, to form a tetrahedral transition state, found in the middle. A Charge rearrangement then releases Cit and Pi.
	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro.<ref>https://www.google.com/#hl=en&sugexp=les%3B&gs_nf=3&gs_mss=Ornithine%20transcarbamylase%20in&tok=0eueaC5bjGY4yeUuw3p3dg&pq=ornithine%20transcarbamylase&cp=37&gs_id=30d&xhr=t&q=Ornithine%20transcarbamylase%20inhibitors&pf=p&safe=off&tbo=d&sclient=psy-ab&oq=Ornithine+transcarbamylase+inhibitors&gs_l=&pbx=1&bav=on.2,or.r_gc.r_pw.r_qf.&fp=689574a48716d7d0&bpcl=38093640&biw=1152&bih=499</ref>		N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro.<ref>https://www.google.com/#hl=en&sugexp=les%3B&gs_nf=3&gs_mss=Ornithine%20transcarbamylase%20in&tok=0eueaC5bjGY4yeUuw3p3dg&pq=ornithine%20transcarbamylase&cp=37&gs_id=30d&xhr=t&q=Ornithine%20transcarbamylase%20inhibitors&pf=p&safe=off&tbo=d&sclient=psy-ab&oq=Ornithine+transcarbamylase+inhibitors&gs_l=&pbx=1&bav=on.2,or.r_gc.r_pw.r_qf.&fp=689574a48716d7d0&bpcl=38093640&biw=1152&bih=499</ref>
-	Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC)(http://www.jbc.org/content/275/26/20012). Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.<ref>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1144443/)</ref>


Line 20:		Line 19:

	===='''Mechanism'''====		===='''Mechanism'''====
		+	[[Image:OTC_reaction.png]]
	The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.		The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi.
	N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro. Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.		N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro. Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). Another inhibitor being studied is The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. In the presence of phaseolotoxin ornithine transcarbamoylase exhibited a transient phase of activity before a steady state.